Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives

Several elements highlight the importance of the mechanistic target of rapamycin (mTOR) in the biology of renal cell carcinoma (RCC). mTOR signaling pathway is indeed frequently activated in RCC, inducing cancer cell proliferation and survival. In addition, mTOR promotes tumor angiogenesis and regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Faes, Seraina, Demartines, Nicolas, Dormond, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005589/
https://www.ncbi.nlm.nih.gov/pubmed/33791295
http://dx.doi.org/10.3389/fcell.2021.636037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005589/
https://www.ncbi.nlm.nih.gov/pubmed/33791295
http://dx.doi.org/10.3389/fcell.2021.636037

Ejemplares similares